| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.076 | 0.6 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |